GlassScriptPhysician profile
Ronald W Hamner
NPI 1467427401
$632.45
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $93.81 · 2022: $79.26.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $284.44 | 2019-2020 | |
| Nxstage Medical, INC. | $79.26 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $45.75 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $42.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $40.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.24 | 2019 | |
| Vifor Pharma, INC. | $23.76 | 2020 | |
| Fresenius USA Marketing, INC. | $19.24 | 2019 | |
| Daiichi Sankyo INC. | $18.45 | 2020 | |
| Amicus Therapeutics, INC. | $18.36 | 2020 | |
| Opko Pharmaceuticals, LLC | $13.01 | 2019 | |
| Shire North American Group INC | $12.52 | 2019 | |
| Intercept Pharmaceuticals, INC. | $10.95 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hamner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.